ATRA treatment significantly reduced the number of induced tumors in Otud6b WT mice but not in Otud6b cKO mice (Figure 7B,C), supporting the notion that ATRA relies on OTUD6B mRNA to suppress ESCC progression. Here, OTUD6B is linked to esophageal squamous cell carcinoma.